DadFinStart your free week
DadFin › Stocks › Healthcare › DXCM

DexCom, Inc. (DXCM) stock score

Healthcare · Medical Devices · United States

$84.11 ▼ -0.36% today

82.9
Dad Score, out of 100
good

DexCom, Inc. (DXCM) is a Medical Devices company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 82.9 out of 100 on the Dad Score, a good reading that places the business ahead of 83% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #151 of 974. Its strongest axes are quality, price action and risk; its weakest is valuation.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Strong
Growth
Average
Price action
Above average
Risk
Strong
Conviction
Strong
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)33.7×
P/E (forward)27.3×
Dividend yield0.00%
Return on capital26.4%
Operating margin24.3%
Revenue growth (YoY)+15.6%
FCF yield3.3%
Net debt / EBITDA-0.39×
Piotroski F-Score7 / 9
52-week change+28.6%
Market cap$32.2B
Next earningsOct 29, 2026

What subscribers see on DXCM

Start your free weekSubscriber? Open the full research →

Medical Devices peers

StockCompanyDad ScoreBandMarket cap
ABTAbbott Laboratories78.9good$169.8B
MDTMedtronic plc90.4strong$110.5B
SYKStryker Corporation86.0strong$105.6B
BSXBoston Scientific Corporation94.3strong$61.7B
EWEdwards Lifesciences Corporation49.4middling$49.0B
GEHCGE HealthCare Technologies Inc.94.5strong$29.2B
PHGKoninklijke Philips N.V.62.3middling$23.4B
STESTERIS plc97.9strong$20.3B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.